State Street SPDR S&P Pharmaceuticals ETF (XPH) — ()

Key Metrics

 

News

XPH: Healthcare Dashboard For January

Published: by:
Sentiment: Positive ()

Healthcare providers have a good value score, and the pharmaceuticals & biotechnology subsector has a good quality score. State Street SPDR S&P Pharmaceuticals ETF provides modified equal-weighted exposure to the …

Read More
image for news XPH: Healthcare Dashboard For January
US and UK agree zero-tariffs on pharmaceuticals

Published: by:
Sentiment: Positive ()

The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products.

Read More
image for news US and UK agree zero-tariffs on pharmaceuticals
XPH: Small-Cap Pharma Turns Higher, At Long Last

Published: by:
Sentiment: Positive ()

SPDR S&P Pharmaceuticals ETF is rated a "Buy" due to compelling valuation and improving technical momentum. XPH offers diversified exposure to large-, mid-, and small-cap pharma stocks, balancing blue-chip stalwarts …

Read More
image for news XPH: Small-Cap Pharma Turns Higher, At Long Last
Trump Trade War: New Tariffs on Drugs, Trucks, and Furniture Raise Inflation Risks

Published: by:
Sentiment: Negative ()

President Trump's new tariffs on drugs, trucks, and furniture reignite trade tensions, boosting U.S. manufacturers but raising global costs, pressuring exporters, and adding inflation risks.

Read More
image for news Trump Trade War: New Tariffs on Drugs, Trucks, and Furniture Raise Inflation Risks
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1

Published: by:
Sentiment: Negative ()

President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on …

Read More
image for news Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
Pharma stocks gain, as Trump's tariff move actually could be a win for the sector

Published: by:
Sentiment: Positive ()

Pharmaceutical stocks mostly gained Friday, as traders appeared to shrug off or even cheer President Donald Trump's rollout of a new tariff plan for drugmakers.

Read More
image for news Pharma stocks gain, as Trump's tariff move actually could be a win for the sector
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit

Published: by:
Sentiment: Negative ()

Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.

Read More
image for news Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
ETFs on the Move Post U.S.-China Trade Deal

Published: by:
Sentiment: Positive ()

Let's delve into the ETF world following the 90-day U.S.-China trade deal.

Read More
image for news ETFs on the Move Post U.S.-China Trade Deal
A Look at Pharma ETFs After Strong Q1 Earnings

Published: by:
Sentiment: Positive ()

Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.

Read More
image for news A Look at Pharma ETFs After Strong Q1 Earnings

About State Street SPDR S&P Pharmaceuticals ETF XPH

The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing